BJCT-BIOJECT-needle less injection product Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : BJCT-BIOJECT-needle less injection product

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: geewiz who wrote (11)	7/6/1997 10:31:00 AM
From: geewiz	of 534

For a comprehensive overview of the science see: doradus.einet.net:8000/galaxy/Business-and-Commerce/General-Products-and-Services/Health-and-Medicine/Supplies-and-Equipment/Drug-Delivery-Devices.html The major established company that is making a similar product is Medi-ject, linked in the above. Medi-ject was incubated by, and is still significantly owned by Becton Dickinson(BDX), a major insulin producer. Target market and customer base were clearly defined at inception. The company completed all development and regulatory approvals before going public. The Medi-ject device is mechanical and is designed to deliver drugs trans-dermally. To acheive an intermuscular injection a greater force is needed that can be acheived with a mechanical device. All vaccines are intermuscular. That's why the nurse will ask patients to stay for a few minutes after an injection, to note any adverse reactions. From the Medi-ject prospectus, page 31 is the following: " Another company, Bioject Inc, has sold a CO2 powered injector since 1993. The injector is designed for and used almost exclusively for vaccinations in doctors' offices or public clinics." Medi-ject is not serious competition to Bioject. The company makes a fine product but for a different market. Many other delivery vectors are in development: ELAN - time release capsules, skin patches March 25,97 news release on FDA approval for Carbatrol (tried a link but it gives expired error) DURA - breath activated inhaler for asthmatics ALKERMES - polymers injected under the skin for slow release THERATECH - skin and gum patches FUISZ - oral drug delivery June 6,97 newsrelease on US patent for Soft-Chew (another expired link) Despite the comfort factor of these oral and transdermal vectors, the vaccine retains its' status as the application of preference for many drugs, see the recent news on polio: dynares.com More exciting is the new field of DNA vaccines. There is an excellent overview of this science in October/96 Scientific America article:

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next